AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 294: R836-R841, 2008. First published December 12, 2007; doi:10.1152/ajpregu.00811.2007
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/3/R836    most recent
00811.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nordquist, L.
Right arrow Articles by Persson, A. E. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nordquist, L.
Right arrow Articles by Persson, A. E. G.

RENAL HEMODYNAMICS AND CARDIORENAL INTEGRATION

Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism

Lina Nordquist,1,* En Yin Lai,1,* Mats Sjöquist,1 Andreas Patzak,1,2 and A. Erik G. Persson1

1Department of Medical Cell Biology, Division of Physiology, University of Uppsala, Uppsala, Sweden; and 2Johannes-Müller-Institute of Physiology, University Hospital Charité Humboldt-University of Berlin, Berlin, Germany

Submitted 7 November 2007 ; accepted in final form 4 December 2007

Objective: an increased glomerular filtration rate (GFR) has been postulated as a potential mechanism involved in the progression of diabetic nephropathy. Studies suggest that C-peptide exerts a renoprotective effect on diabetes. The peptide decreases hyperfiltration in patients with type 1 diabetes, as well as in diabetic animal models. In this study, we investigated whether C-peptide causes a change in arteriolar diameter. Research Design and Methods: C57-Bl mice were made diabetic by means of a single intravenous injection of alloxan 2 wk prior to the experiment. Age-matched normoglycemic mice served as controls. Afferent arterioles, intact with the glomeruli, were dissected and microperfused. The effect of luminal application of C-peptide, compared with scrambled C-peptide or vehicle, was investigated. The effect of the Rho-kinase inhibitor Y-27632 was also investigated. Results: C-peptide constricted afferent arterioles in diabetic mice by –27% compared with the control value. Normoglycemic arterioles administered C-peptide displayed a delayed and minute response (–4%). Scrambled C-peptide or vehicle administration, whether administered to hyperglycemic or normoglycemic mice, did not induce any effect. Addition of Y-27632 abolished the effect of C-peptide. Conclusion: C-peptide induces constriction of afferent arterioles in diabetic mice. This can reduce enhanced GFR and may be one of the mechanisms in the renoprotective action of C-peptide in diabetes.

diabetes; glomerular filtration rate; renal function



Address for reprint requests and other correspondence: A. E. G. Persson, Uppsala Univ., Dept. of Medical Cell Biology, Biomedical Centre, Box 571, 751 23 Uppsala, Sweden (e-mail: Erik.Persson{at}mcb.uu.se)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.